2‐Mercaptonicotinoyl glycine prevents UV‐induced skin darkening and delayed tanning in healthy subjects: A randomized controlled clinical study

Background Chronic nonextreme sun exposure induces two mechanisms of skin pigmentation, causing immediate darkening and delayed tanning. A new molecule, 2‐mercaptonicotinoyl glycine (2‐MNG), has been shown in vitro to inhibit both immediate darkening and new melanin synthesis via covalent conjugatio...

Full description

Saved in:
Bibliographic Details
Published inJournal of cosmetic dermatology Vol. 23; no. 5; pp. 1745 - 1752
Main Authors Dormael, R., Sextius, P., Bourokba, N., Mainguene, E., Tachon, R., Gaurav, K., Jouni, H., Bastien, P., Diridollou, S.
Format Journal Article
LanguageEnglish
Published England 01.05.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Chronic nonextreme sun exposure induces two mechanisms of skin pigmentation, causing immediate darkening and delayed tanning. A new molecule, 2‐mercaptonicotinoyl glycine (2‐MNG), has been shown in vitro to inhibit both immediate darkening and new melanin synthesis via covalent conjugation of the thiol group of 2‐MNG to melanin precursors. Objective To evaluate 2‐MNG in preventing both mechanisms in vivo. Methods In a randomized, intra‐individual and controlled study, 33 subjects with melanin‐rich skin were exposed to UV daylight on designated areas on the back and treated with a cosmetic formula containing 0.5% or 1% 2‐MNG alone or 0.5% 2‐MNG in association with lipohydroxy acid (LHA, 0.3%) plus Mexoryl‐SX (MSX, 1.5%). The respective vehicles were used as controls and 4‐n‐butyl‐resorcinol (4‐n‐BR, 2.5%) as a positive reference. Results 2‐MNG alone significantly reduced immediate darkening and inhibited new melanin production when compared with vehicle, with higher performance at 1% than at 0.5%. 2‐MNG at 0.5% in association with LHA and MSX showed significantly higher performance than 2‐MNG 0.5% alone. 2‐MNG at 0.5% and 1% showed significantly better performance than 4‐n‐BR. Conclusions 2‐MNG inhibited both UV‐induced skin pigmentation mechanisms in vivo. The association of 2‐MNG with LHA plus MSX showed the highest efficacy on melanin‐rich skin with pigmentation induced by UV exposure.
AbstractList Chronic nonextreme sun exposure induces two mechanisms of skin pigmentation, causing immediate darkening and delayed tanning. A new molecule, 2-mercaptonicotinoyl glycine (2-MNG), has been shown in vitro to inhibit both immediate darkening and new melanin synthesis via covalent conjugation of the thiol group of 2-MNG to melanin precursors.BACKGROUNDChronic nonextreme sun exposure induces two mechanisms of skin pigmentation, causing immediate darkening and delayed tanning. A new molecule, 2-mercaptonicotinoyl glycine (2-MNG), has been shown in vitro to inhibit both immediate darkening and new melanin synthesis via covalent conjugation of the thiol group of 2-MNG to melanin precursors.To evaluate 2-MNG in preventing both mechanisms in vivo.OBJECTIVETo evaluate 2-MNG in preventing both mechanisms in vivo.In a randomized, intra-individual and controlled study, 33 subjects with melanin-rich skin were exposed to UV daylight on designated areas on the back and treated with a cosmetic formula containing 0.5% or 1% 2-MNG alone or 0.5% 2-MNG in association with lipohydroxy acid (LHA, 0.3%) plus Mexoryl-SX (MSX, 1.5%). The respective vehicles were used as controls and 4-n-butyl-resorcinol (4-n-BR, 2.5%) as a positive reference.METHODSIn a randomized, intra-individual and controlled study, 33 subjects with melanin-rich skin were exposed to UV daylight on designated areas on the back and treated with a cosmetic formula containing 0.5% or 1% 2-MNG alone or 0.5% 2-MNG in association with lipohydroxy acid (LHA, 0.3%) plus Mexoryl-SX (MSX, 1.5%). The respective vehicles were used as controls and 4-n-butyl-resorcinol (4-n-BR, 2.5%) as a positive reference.2-MNG alone significantly reduced immediate darkening and inhibited new melanin production when compared with vehicle, with higher performance at 1% than at 0.5%. 2-MNG at 0.5% in association with LHA and MSX showed significantly higher performance than 2-MNG 0.5% alone. 2-MNG at 0.5% and 1% showed significantly better performance than 4-n-BR.RESULTS2-MNG alone significantly reduced immediate darkening and inhibited new melanin production when compared with vehicle, with higher performance at 1% than at 0.5%. 2-MNG at 0.5% in association with LHA and MSX showed significantly higher performance than 2-MNG 0.5% alone. 2-MNG at 0.5% and 1% showed significantly better performance than 4-n-BR.2-MNG inhibited both UV-induced skin pigmentation mechanisms in vivo. The association of 2-MNG with LHA plus MSX showed the highest efficacy on melanin-rich skin with pigmentation induced by UV exposure.CONCLUSIONS2-MNG inhibited both UV-induced skin pigmentation mechanisms in vivo. The association of 2-MNG with LHA plus MSX showed the highest efficacy on melanin-rich skin with pigmentation induced by UV exposure.
Chronic nonextreme sun exposure induces two mechanisms of skin pigmentation, causing immediate darkening and delayed tanning. A new molecule, 2-mercaptonicotinoyl glycine (2-MNG), has been shown in vitro to inhibit both immediate darkening and new melanin synthesis via covalent conjugation of the thiol group of 2-MNG to melanin precursors. To evaluate 2-MNG in preventing both mechanisms in vivo. In a randomized, intra-individual and controlled study, 33 subjects with melanin-rich skin were exposed to UV daylight on designated areas on the back and treated with a cosmetic formula containing 0.5% or 1% 2-MNG alone or 0.5% 2-MNG in association with lipohydroxy acid (LHA, 0.3%) plus Mexoryl-SX (MSX, 1.5%). The respective vehicles were used as controls and 4-n-butyl-resorcinol (4-n-BR, 2.5%) as a positive reference. 2-MNG alone significantly reduced immediate darkening and inhibited new melanin production when compared with vehicle, with higher performance at 1% than at 0.5%. 2-MNG at 0.5% in association with LHA and MSX showed significantly higher performance than 2-MNG 0.5% alone. 2-MNG at 0.5% and 1% showed significantly better performance than 4-n-BR. 2-MNG inhibited both UV-induced skin pigmentation mechanisms in vivo. The association of 2-MNG with LHA plus MSX showed the highest efficacy on melanin-rich skin with pigmentation induced by UV exposure.
Background Chronic nonextreme sun exposure induces two mechanisms of skin pigmentation, causing immediate darkening and delayed tanning. A new molecule, 2‐mercaptonicotinoyl glycine (2‐MNG), has been shown in vitro to inhibit both immediate darkening and new melanin synthesis via covalent conjugation of the thiol group of 2‐MNG to melanin precursors. Objective To evaluate 2‐MNG in preventing both mechanisms in vivo. Methods In a randomized, intra‐individual and controlled study, 33 subjects with melanin‐rich skin were exposed to UV daylight on designated areas on the back and treated with a cosmetic formula containing 0.5% or 1% 2‐MNG alone or 0.5% 2‐MNG in association with lipohydroxy acid (LHA, 0.3%) plus Mexoryl‐SX (MSX, 1.5%). The respective vehicles were used as controls and 4‐n‐butyl‐resorcinol (4‐n‐BR, 2.5%) as a positive reference. Results 2‐MNG alone significantly reduced immediate darkening and inhibited new melanin production when compared with vehicle, with higher performance at 1% than at 0.5%. 2‐MNG at 0.5% in association with LHA and MSX showed significantly higher performance than 2‐MNG 0.5% alone. 2‐MNG at 0.5% and 1% showed significantly better performance than 4‐n‐BR. Conclusions 2‐MNG inhibited both UV‐induced skin pigmentation mechanisms in vivo. The association of 2‐MNG with LHA plus MSX showed the highest efficacy on melanin‐rich skin with pigmentation induced by UV exposure.
Author Sextius, P.
Tachon, R.
Jouni, H.
Mainguene, E.
Gaurav, K.
Diridollou, S.
Bourokba, N.
Bastien, P.
Dormael, R.
Author_xml – sequence: 1
  givenname: R.
  orcidid: 0000-0001-7160-0570
  surname: Dormael
  fullname: Dormael, R.
  email: romain.dedormael@loreal.com
  organization: L'Oréal Research and Innovation
– sequence: 2
  givenname: P.
  orcidid: 0000-0002-8710-6582
  surname: Sextius
  fullname: Sextius, P.
  organization: L'Oréal Research and Innovation
– sequence: 3
  givenname: N.
  orcidid: 0000-0001-7429-7490
  surname: Bourokba
  fullname: Bourokba, N.
  organization: L'Oréal Research and Innovation
– sequence: 4
  givenname: E.
  orcidid: 0000-0001-8402-9721
  surname: Mainguene
  fullname: Mainguene, E.
  organization: L'Oréal Research and Innovation
– sequence: 5
  givenname: R.
  orcidid: 0000-0002-0997-7470
  surname: Tachon
  fullname: Tachon, R.
  organization: L'Oréal Research and Innovation
– sequence: 6
  givenname: K.
  orcidid: 0000-0003-4142-7521
  surname: Gaurav
  fullname: Gaurav, K.
  organization: L'Oréal Research and Innovation
– sequence: 7
  givenname: H.
  orcidid: 0000-0003-4641-3161
  surname: Jouni
  fullname: Jouni, H.
  organization: L'Oréal Research and Innovation
– sequence: 8
  givenname: P.
  orcidid: 0000-0002-5602-5827
  surname: Bastien
  fullname: Bastien, P.
  organization: L'Oréal Research and Innovation
– sequence: 9
  givenname: S.
  orcidid: 0000-0002-1272-1927
  surname: Diridollou
  fullname: Diridollou, S.
  organization: L'Oréal Research and Innovation
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38372022$$D View this record in MEDLINE/PubMed
BookMark eNp90c1OGzEQAGCrApW_XniAyseqUsBeZ_96Q2kprUBcSK-rWXuSODh2antB2xOPUIk35ElwCOSAEL7Y8nwzlmf2yJZ1Fgk55OyIp3U8d1Id8SJj7APZ5cNSDDJe5Fubs2A7ZC-EOWO8rHn-keyISpQZy7Jdcp893P2_QC9hGZ3V0kVtXW_o1PRSW6RLjzdoY6DjPwlqqzqJioZrbakCf41W2ykFq6hCA30KRbBPdwnMEEyc9TR07RxlDN_oCfXJuoX-l6R0NnpnzOpodHobDA2xU_0B2Z6ACfjped8n49MfV6Ozwfnlz1-jk_OBFEXOBihAAVaqUJBDIVpsh3X6lQAoVd5OWK0QWl6jqBWfSFXmKItKpFAFIvFc7JMv67pL7_52GGKz0EGiMWDRdaHJ6qzKq6IaikQ_P9OuXaBqll4vwPfNSyMT-LoG0rsQPE42hLNmNaVmNaXmaUoJs1dY6ghRrxoC2rydwtcpt9pg_07x5vfl6Ps65xFAzqp2
CitedBy_id crossref_primary_10_1111_jocd_16735
crossref_primary_10_1111_jdv_19910
crossref_primary_10_1111_pcmr_13168
crossref_primary_10_3390_cosmetics11060220
Cites_doi 10.1271/bbb.69.2368
10.1111/exd.14260
10.1111/j.1529-8019.2007.00144.x
10.1111/phpp.12497
10.1111/jdv.18948
10.1111/bjd.12536
10.1002/em.2850260310
10.1097/01.DER.0000438425.56740.8a
10.1111/j.1473-2165.2007.00296.x
10.1111/srt.12877
10.1046/j.1524-4725.1999.08236.x
10.1111/j.1755-148X.2010.00764.x
10.1111/jdv.12051
10.1046/j.0022-202X.2004.22223.x
10.1111/j.1529-8019.2006.00085.x
10.1111/j.1600-0781.2008.00365.x
10.1111/j.1751-1097.2005.tb01456.x
10.1007/s00018-005-5054-y
10.1039/c2pp25152c
ContentType Journal Article
Copyright 2024 Loreal. published by Wiley Periodicals LLC.
2024 Loreal. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.
Copyright_xml – notice: 2024 Loreal. published by Wiley Periodicals LLC.
– notice: 2024 Loreal. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/jocd.16200
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1473-2165
EndPage 1752
ExternalDocumentID 38372022
10_1111_jocd_16200
JOCD16200
Genre article
Randomized Controlled Trial
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
1OC
24P
29K
31~
33P
36B
3SF
4.4
50Y
50Z
52M
52O
52T
52U
52V
52W
53G
5GY
5HH
5VS
702
7PT
7X7
8-0
8-1
8-3
8-4
8-5
8FI
8FJ
930
A01
A03
AAESR
AAEVG
AAHHS
AAKAS
AANHP
AAONW
AASGY
AAXRX
AAZKR
ABCUV
ABDBF
ABJNI
ABPVW
ABUWG
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCMX
ACCZN
ACGFS
ACMXC
ACPOU
ACRPL
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADPDF
ADXAS
ADZCM
ADZMN
AEEZP
AEGXH
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFEBI
AFGKR
AFKRA
AFPWT
AFZJQ
AIACR
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BENPR
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
C45
CAG
CCPQU
COF
CS3
D-6
D-7
D-E
D-F
D-I
DCZOG
DPXWK
DRFUL
DRMAN
DRSTM
EAD
EAP
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F21
F5P
FEDTE
FUBAC
FYUFA
G-S
G.N
GODZA
H.X
HF~
HMCUK
HVGLF
HZ~
IHE
KBYEO
LATKE
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY~
N04
N05
NF~
O66
O9-
OIG
OVD
OVEED
P2P
P2W
P2X
P2Z
P4B
P4D
PIMPY
Q.N
QB0
R.K
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
UKHRP
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WVDHM
YFH
YUY
ZZTAW
~IA
~WT
AAYXX
AGQPQ
CITATION
PHGZM
PHGZT
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c3650-e3adae8d6da5a63beb497203aa7d5bf09deab19e39d1fcd75ec683d5b8a363b53
IEDL.DBID 24P
ISSN 1473-2130
1473-2165
IngestDate Fri Jul 11 04:23:23 EDT 2025
Mon Jul 21 06:04:54 EDT 2025
Tue Jul 01 02:37:53 EDT 2025
Thu Apr 24 22:57:51 EDT 2025
Wed Jan 22 17:19:32 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords mercaptoniacinamide (2‐MNG)
topical
anti‐pigmenting
anti‐oxidation
Language English
License Attribution
2024 Loreal. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3650-e3adae8d6da5a63beb497203aa7d5bf09deab19e39d1fcd75ec683d5b8a363b53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-0997-7470
0000-0003-4641-3161
0000-0002-1272-1927
0000-0001-7160-0570
0000-0002-5602-5827
0000-0003-4142-7521
0000-0001-8402-9721
0000-0001-7429-7490
0000-0002-8710-6582
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjocd.16200
PMID 38372022
PQID 2928586843
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_2928586843
pubmed_primary_38372022
crossref_primary_10_1111_jocd_16200
crossref_citationtrail_10_1111_jocd_16200
wiley_primary_10_1111_jocd_16200_JOCD16200
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate May 2024
2024-05-00
2024-May
20240501
PublicationDateYYYYMMDD 2024-05-01
PublicationDate_xml – month: 05
  year: 2024
  text: May 2024
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of cosmetic dermatology
PublicationTitleAlternate J Cosmet Dermatol
PublicationYear 2024
References 2004; 122
2022; 2022
2013; 27
2023
1995; 26
2023; 37
2013; 12
2019; 35
2019; 12
1999; 25
2005; 62
2013; 169
2020; 26
2005; 75
2014; 25
2007; 6
2006; 19
2008; 24
2011; 24
2005; 81
2007; 20
2021; 30
2005; 69
e_1_2_13_13_1
e_1_2_13_25_1
e_1_2_13_14_1
e_1_2_13_24_1
e_1_2_13_15_1
e_1_2_13_16_1
e_1_2_13_21_1
e_1_2_13_10_1
e_1_2_13_20_1
e_1_2_13_23_1
e_1_2_13_22_1
e_1_2_13_9_1
e_1_2_13_8_1
e_1_2_13_7_1
e_1_2_13_6_1
Xing X (e_1_2_13_11_1) 2022; 2022
Phillips TJ (e_1_2_13_17_1) 2005; 75
e_1_2_13_5_1
e_1_2_13_4_1
e_1_2_13_3_1
e_1_2_13_2_1
e_1_2_13_18_1
Dormael R (e_1_2_13_12_1) 2019; 12
e_1_2_13_19_1
References_xml – volume: 12
  start-page: E53
  issue: 2
  year: 2019
  end-page: E59
  article-title: Vitamin C prevents ultraviolet‐induced pigmentation in healthy volunteers: Bayesian meta‐analysis results from 31 randomized controlled versus vehicle clinical studies
  publication-title: J Clin Aesthet Dermatol
– volume: 26
  start-page: 794
  year: 2020
  end-page: 803
  article-title: In vivo multiphoton imaging for non‐invasive time course assessment of retinoids effects on human skin
  publication-title: Skin Res Technol
– volume: 169
  start-page: 41
  issue: Suppl 3
  year: 2013
  end-page: 56
  article-title: Facial hyperpigmentation: causes and treatment
  publication-title: Br J Dermatol
– volume: 6
  start-page: 59
  issue: 1
  year: 2007
  end-page: 65
  article-title: The use of hydroxy acids on the skin: characteristics of C8‐lipohydroxy acid
  publication-title: J Cosmet Dermatol
– volume: 2022
  issue: 18
  year: 2022
  article-title: Implications of oxidative stress in the pathogenesis and treatment of hyperpigmentation disorders
  publication-title: Oxidative Med Cell Longev
– volume: 37
  start-page: 3
  issue: S4
  year: 2023
  end-page: 11
  article-title: A precise analysis of the relative contribution of UVA1 and visible light colour domains in solar light‐induced skin pigmentation
  publication-title: J Eur Acad Dermatol Venereol
– volume: 62
  start-page: 1707
  issue: 15
  year: 2005
  end-page: 1723
  article-title: Tyrosinase inhibitors from natural and synthetic sources: structure, inhibition mechanism and perspective for the future
  publication-title: Cell Mol Life Sci
– volume: 19
  start-page: 280
  issue: 5
  year: 2006
  end-page: 288
  article-title: Retinoid therapy of pigmentary disorders
  publication-title: Dermatol Ther
– volume: 25
  start-page: 282
  issue: 4
  year: 1999
  end-page: 284
  article-title: Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid
  publication-title: Dermatologic Surg
– volume: 20
  start-page: 308
  issue: 5
  year: 2007
  end-page: 313
  article-title: Skin lightening preparations and the hydroquinone controversy
  publication-title: Dermatol Ther
– volume: 75
  start-page: 14
  issue: 2 Suppl
  year: 2005
  end-page: 22
  article-title: An update on the safety and efficacy of topical retinoids
  publication-title: Cutis
– volume: 12
  start-page: 54
  issue: 1
  year: 2013
  end-page: 64
  article-title: Effects of ultraviolet radiation, visible light, and infrared radiation on erythema and pigmentation: a review
  publication-title: Photochem Photobiol Sci
– volume: 24
  start-page: 136
  issue: 1
  year: 2011
  end-page: 147
  article-title: The deceptive nature of UVA tanning versus the modest protective effects of UVB tanning on human skin
  publication-title: Pigment Cell Melanoma Res
– volume: 26
  start-page: 248
  issue: 3
  year: 1995
  end-page: 254
  article-title: Taurine and ellagic acid: two differently‐acting natural antioxidants
  publication-title: Environ Mol Mutagen
– volume: 35
  start-page: 387
  issue: 6
  year: 2019
  end-page: 392
  article-title: The dynamics of pigment reactions of human skin to ultraviolet a radiation
  publication-title: Photodermatol Photoimmunol Photomed
– year: 2023
– volume: 25
  start-page: e1
  issue: 1
  year: 2014
  end-page: e5
  article-title: Hydroquinone‐induced depigmentation: case report and review of the literature
  publication-title: Dermatitis
– volume: 69
  start-page: 2368
  issue: 12
  year: 2005
  end-page: 2373
  article-title: Inhibitory effect of an ellagic acid‐rich pomegranate extract on tyrosinase activity and ultraviolet‐induced pigmentation
  publication-title: Biosci Biotechnol Biochem
– volume: 122
  start-page: 503
  issue: 2
  year: 2004
  end-page: 509
  article-title: Involvement of photooxidation of melanogenic precursors in prolonged pigmentation induced by ultraviolet a
  publication-title: J Invest Dermatol
– volume: 30
  start-page: 560
  issue: 4
  year: 2021
  end-page: 571
  article-title: Skin pigmentation and its control: from ultraviolet radiation to stem cells
  publication-title: Exp Dermatol
– volume: 27
  start-page: 19
  issue: Suppl. S1
  year: 2013
  end-page: 23
  article-title: 4‐n‐butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation
  publication-title: J Eur Acad Dermatol Venereol
– volume: 24
  start-page: 164
  issue: 4
  year: 2008
  end-page: 174
  article-title: Sunscreens containing the broad‐spectrum UVA absorber, Mexoryl SX, prevent the cutaneous detrimental effects of UV exposure: a review of clinical study results
  publication-title: Photodermatol Photoimmunol Photomed
– volume: 81
  start-page: 874
  year: 2005
  end-page: 878
  article-title: Standard ultraviolet daylight for nonextreme exposure conditions
  publication-title: Photochem Photobiol
– ident: e_1_2_13_14_1
  doi: 10.1271/bbb.69.2368
– ident: e_1_2_13_2_1
  doi: 10.1111/exd.14260
– ident: e_1_2_13_18_1
  doi: 10.1111/j.1529-8019.2007.00144.x
– ident: e_1_2_13_6_1
  doi: 10.1111/phpp.12497
– ident: e_1_2_13_21_1
– ident: e_1_2_13_25_1
  doi: 10.1111/jdv.18948
– ident: e_1_2_13_10_1
  doi: 10.1111/bjd.12536
– ident: e_1_2_13_13_1
  doi: 10.1002/em.2850260310
– ident: e_1_2_13_19_1
  doi: 10.1097/01.DER.0000438425.56740.8a
– ident: e_1_2_13_22_1
  doi: 10.1111/j.1473-2165.2007.00296.x
– ident: e_1_2_13_15_1
  doi: 10.1111/srt.12877
– ident: e_1_2_13_8_1
  doi: 10.1046/j.1524-4725.1999.08236.x
– volume: 2022
  issue: 18
  year: 2022
  ident: e_1_2_13_11_1
  article-title: Implications of oxidative stress in the pathogenesis and treatment of hyperpigmentation disorders
  publication-title: Oxidative Med Cell Longev
– ident: e_1_2_13_3_1
  doi: 10.1111/j.1755-148X.2010.00764.x
– ident: e_1_2_13_9_1
  doi: 10.1111/jdv.12051
– ident: e_1_2_13_4_1
  doi: 10.1046/j.0022-202X.2004.22223.x
– ident: e_1_2_13_16_1
  doi: 10.1111/j.1529-8019.2006.00085.x
– volume: 75
  start-page: 14
  issue: 2
  year: 2005
  ident: e_1_2_13_17_1
  article-title: An update on the safety and efficacy of topical retinoids
  publication-title: Cutis
– ident: e_1_2_13_20_1
– volume: 12
  start-page: E53
  issue: 2
  year: 2019
  ident: e_1_2_13_12_1
  article-title: Vitamin C prevents ultraviolet‐induced pigmentation in healthy volunteers: Bayesian meta‐analysis results from 31 randomized controlled versus vehicle clinical studies
  publication-title: J Clin Aesthet Dermatol
– ident: e_1_2_13_23_1
  doi: 10.1111/j.1600-0781.2008.00365.x
– ident: e_1_2_13_24_1
  doi: 10.1111/j.1751-1097.2005.tb01456.x
– ident: e_1_2_13_7_1
  doi: 10.1007/s00018-005-5054-y
– ident: e_1_2_13_5_1
  doi: 10.1039/c2pp25152c
SSID ssj0017915
Score 2.3490536
Snippet Background Chronic nonextreme sun exposure induces two mechanisms of skin pigmentation, causing immediate darkening and delayed tanning. A new molecule,...
Chronic nonextreme sun exposure induces two mechanisms of skin pigmentation, causing immediate darkening and delayed tanning. A new molecule,...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1745
SubjectTerms Adult
anti‐oxidation
anti‐pigmenting
Female
Glycine - administration & dosage
Glycine - analogs & derivatives
Glycine - pharmacology
Healthy Volunteers
Humans
Male
Melanins - radiation effects
mercaptoniacinamide (2‐MNG)
Middle Aged
Skin - drug effects
Skin - metabolism
Skin - radiation effects
Skin Pigmentation - drug effects
Skin Pigmentation - radiation effects
Sunbathing
topical
Ultraviolet Rays - adverse effects
Young Adult
Title 2‐Mercaptonicotinoyl glycine prevents UV‐induced skin darkening and delayed tanning in healthy subjects: A randomized controlled clinical study
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjocd.16200
https://www.ncbi.nlm.nih.gov/pubmed/38372022
https://www.proquest.com/docview/2928586843
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NatwwEB7SBEIvpW3Sdts0KCSXBFzWlmxLoZc0P4TAJiFkw96M5NGWpVt7ib2H7amPUOgb9kk6kr0moaXQixFobIM_j2ZGM_MJYM-mVhttooDsKQZC8CTQCsMgshRLKI1hX7re4cFlcj4UF6N4tAIfl70wDT9Et-HmNMOv107BtakeKnmZ44cwIZSfwJrrrXXM-ZG47nIIqfLnF4Qi5UFES3VLTurreLp7H5ujP3zMxy6rtzlnz-FZ6yyyowbdF7Bii5ewPmjT4RvwM_r1_cfA3ud6VjuK27KeFOViyj5PF06AzRp-pooN70iQom_CEVn1ZVIwdGU5bk-E6QKZo4pc0FTdnGDESKBpkFywam7cVk11yI4Y2TUsv06-kWRb4j51w7a5knmq2k0Ynp3eHp8H7SkLQc7JPQss16itxAR1rBNurBHK5Wa1TjE2475CQjNUlhOE4xzT2OaJ5DQlNSfxmL-C1aIs7BtgZPzHFG9rqcjNCmMrOUfso-CoZC6M6cH-8mNneUtB7k7CmGZdKELAZB6YHux2srOGeOOvUjtLzDLSC5fs0IUt51UWqUjGMpGC9-B1A2b3HBeVR-S89ODAo_uPF2QXV8cnfvT2f4TfwVN6gWgqI7dgtb6f2_fkvdRm2_-kdE1H6TasfTq9vL75DWzV8e4
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NbtQwEB5BkaAXVP4XWjCCC0ipNraT2L1VLdVSuoVDF_UW2RkvWrFNVk32sD31EZD6hjwJYyeNqEBI3Cx5Ekv5Mp7_GYC3LnPGGssjkqcYSSnSyGiMI-7IltAG46HytcPj43Q0kYenyWmXm-NrYdr-EL3DzXNGuK89g3uH9O9cXhW4HacE8224I1Oeeb7k8ksfRMh0GGAQy0xEnO7qrjtpSOTpn70pj_5QMm_qrEHoHGzA_U5bZLstvA_glisfwt1xFw9_BFf85-WPsTsvzKLxPW6rZlZWqzn7Nl95ArZoGzTVbPKVCMn8JiCR1d9nJUOfl-OdIsyUyHyvyBVtNe0II0YEbYXkitVL63019Q7bZSTYsDqbXRBll-M-98uuupKFXrWPYXLw4WRvFHVjFqJCkH4WOWHQOIUpmsSkwjortQ_OGpNhYqdDjQRnrJ0gDKcFZokrUiVoSxlB5Il4AmtlVbpnwEj6T8ngNkqTnhUnTgmBOEQpUKtCWjuAd9cfOy-6HuR-FMY8720RAiYPwAzgTU-7aDtv_JXq9TVmOTGGj3aY0lXLOueaq0SlSooBPG3B7N_jzXJO2ssA3gd0_3FAfvh5bz-snv8P8Su4NzoZH-VHH48_vYB1Oky2aZKbsNacL90WqTKNfRl-2F8tsvLZ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NbtQwEB61Rap6QS0_7baUGsEFpKBN7CR2xaVquyqFLT2wqLfIznjRiiVZNdnD9sQjIPGGfRLGTjaiAiH1ZsmTWMqX8cx4xt8AvLKp1UabKCB7ioEQPAm0wjCILMUSSmPYl-7u8PAiORuJ86v4agXeLe_CNPwQ3YGb0wy_XzsFn-H4TyUvc3wbJoTyKjzw2T7H6ywuuxxCqnz_glCkPIhoq27JSX0dT_fsXXP0l49512X1NmewCQ9bZ5EdNehuwYotHsH6sE2HP4Zf0e2Pn0N7netZ7Shuy3pSlIsp-zpdOAE2a_iZKjb6QoIUfROOyKpvk4KhK8txZyJMF8gcVeSCpuqmgxEjgeaC5IJVc-OOaqpDdsTIrmH5fXJDkm2J-9QN28uVzFPVPoHR4PTz8VnQdlkIck7uWWC5Rm0lJqhjnXBjjVAuN6t1irEZ9xUSmqGynCAc55jGNk8kpympOYnH_CmsFWVhd4CR8R9TvK2lIjcrjK3kHLGPgqOSuTCmB6-XHzvLWwpy1wljmnWhCAGTeWB68LKTnTXEG_-UerHELCO9cMkOXdhyXmWRimQsEyl4D7YbMLv3uKg8IuelB288uv9ZIDv_dHziR7v3ET6A9cuTQfbx_cWHPdigtURTJPkM1urrud0nR6Y2z_3_-hvV3PIL
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2-Mercaptonicotinoyl+glycine+prevents+UV-induced+skin+darkening+and+delayed+tanning+in+healthy+subjects%3A+A+randomized+controlled+clinical+study&rft.jtitle=Journal+of+cosmetic+dermatology&rft.au=de+Dormael%2C+R&rft.au=Sextius%2C+P&rft.au=Bourokba%2C+N&rft.au=Mainguene%2C+E&rft.date=2024-05-01&rft.issn=1473-2165&rft.eissn=1473-2165&rft.volume=23&rft.issue=5&rft.spage=1745&rft_id=info:doi/10.1111%2Fjocd.16200&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1473-2130&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1473-2130&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1473-2130&client=summon